Cited by 23Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsParaoxonase enzyme and polymorphisms

A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan

for the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group, Hirata, Takumi, Sugiyama, Daisuke, Nagasawa, Shin-ya, Murakami, Yoshitaka, Saitoh, Shigeyuki, Okayama, Akira, Iso, Hiroyasu +8 more·2017·European Journal of Epidemiology

Abstract

Low levels of serum high-density lipoprotein cholesterol (HDL-C) have been shown to be associated with increased risk of coronary heart disease (CHD). However, because this is usually observed in the context of other lipid abnormalities, it is not known whether isolated low serum HDL-C levels are an independent risk factor for CHD. We performed a large pooled analysis in Japan using data from nine cohorts with 41,206 participants aged 40-89 years who were free of cardiovascular disease at baseline. We divided participants into three groups: isolated low HDL-C, non-isolated low HDL-C, and normal HDL-C. Cohort-stratified Cox proportional hazards models were used to estimate multivariate-adjusted hazard ratios (HRs) for death due to CHD, ischemic stroke, and intracranial cerebral hemorrhage; during a 12.9-year follow-up, we observed 355, 286, and 138 deaths, respectively, in these groups. Non-isolated low HDL-C was significantly associated with increased risk of CHD compared with normal HDL-C (HR 1.37, 95 % confidence interval (CI) 1.04-1.80); however, isolated low HDL-C was not. Although isolated low HDL-C was significantly associated with decreased risk of CHD (HR 0.51, 95 % CI 0.29-0.89) in women, it was significantly associated with increased risk of intracranial cerebral hemorrhage in all participants (HR 1.62, 95 % CI 1.04-2.53) and in men (HR 2.00, 95 % CI 1.04-3.83). In conclusion, isolated low HDL-C levels are not associated with increased risk of CHD in Japan. CHD risk may, therefore, be more strongly affected by serum total cholesterol levels in this population.

Integrity signals

Registry

Crossref · 10.1007/s10654-016-0203-1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A decreased HDL-C level alone is a risk factor for CAD when LDL-C and TG levels are within the normal range, especially in Asia.

    “Studies conducted in 23 countries in Asia and Oceania, including Japan, have shown that a decreased HDL-C level alone also becomes a risk factor for CAD when both the LDL-C and TG levels are within the normal range, and this is especially so in Asia83).”
  • If non-HDL-C levels are used for screening in the general population, the difference between the non-HDL-C and LDL-C levels would be <30 mg/dL, at approximately 20 mg/dL.

    “If non-HDL-C levels are used for screening in the general population, then it should also be noted that the difference between the non-HDL-C and LDL-C levels would be < 30 mg/dL, at approximately 20 mg/dL349, 350).”

The citation lists haven’t been fetched yet

References 40 · Cited by 23

Authors
for the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group, Hirata, T., Sugiyama, D., Nagasawa, S.-Y., Murakami, Y., Saitoh, S., Okayama, A., Iso, H., Irie, F., Sairenchi, T., Miyamoto, Y., Yamada, M., Ishikawa, S., Miura, K., Ueshima, H., & Okamura, T.
Affiliations
  • Keio University (JP)
  • Kanazawa Medical University (JP)
  • Toho University (JP)
  • Sapporo Medical University (JP)
  • Research Institute of Strategy for Prevention (Japan) (JP)
  • The University of Osaka (JP)
  • Ibaraki Prefectural Government (JP)
  • Dokkyo University (JP)
  • National Cerebral and Cardiovascular Center (JP)
  • Radiation Effects Research Foundation (JP)
  • Jichi Medical University (JP)
  • Shiga University of Medical Science (JP)
Corresponding author
Hirata, Takumi
Venue
European Journal of Epidemiology
Published
2016-10-05
Volume
32
Issue
7
Pages
547-557
ISSN
  • 0393-2990 (ISSN-L)
  • 1573-7284
OpenAlex
W2528274397
Cited by
23
References
40
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 6 · 2018: 4 · 2017: 3
FWCI
4.81
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
Funders
Ministry of Health, Labour and Welfare (Health and Labor Sciences research grants, Japan; Research on Health Services: H17–Kenkou–007, Health and Labor Sciences research grants, Japan; Comprehensive Research on Cardiovascular Disease and Life–Style Related Disease: H18–Junkankitou [Seishuu]–Ippan–012, Health and Labor Sciences research grants, Japan; Comprehensive Research on Cardiovascular Disease and Life–Style Related Disease: H19–Junkankitou [Seishuu]–Ippan–012, Health and Labor Sciences research grants, Japan; Comprehensive Research on Cardiovascular Disease and Life–Style Related Disease: H20–Junkankitou [Seishuu]–Ippan–013, Health and Labor Sciences research grants, Japan; Comprehensive Research on Cardiovascular Disease and Life–Style Related Disease: H23–Junkankitou [Seishuu]–Ippan–005, Health and Labor Sciences research grants, Japan; Comprehensive Research on Cardiovascular Disease and Life–Style Related Disease: H26-Junkankitou [Seisaku]-Ippan-001)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords
HDL cholesterol, cardiovascular mortality, coronary artery disease, ischemic stroke, total cholesterol, sex differences, Japanese population
MeSH terms
Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Coronary Disease, Female, Follow-Up Studies, Humans, Japan, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Cohort Studies, Biomarkers, Proportional Hazards Models, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review